All of the major movement disorders (Parkinson's disease, Huntington's disease, Tourette syndrome) have important associated psychiatric dimensions. These if co-occurring together, cause signicant clinical burden and effect patients' quality of life and prognosis gets affected. Similarly, many of the major psychiatric disorders (such as Schizophrenia and Depression), involve abnormalities of movement. Many psychotropic medications are also known to cause movement disorders. A clinician should always assess the psychiatric comorbidities in relation to movement disorders that will help to build a holistic and pragmatic approach to management and consequently, improve the quality of life of the patient.

A seizure is defined as transient change in neurological functioning which is characterised by hypersynchronous discharges of neurons in the brain regions whereas epilepsy is defined as a syndrome consisting of various recurrent seizures and it is associated with the psychological and neuropathological effects. Early recognition and management of psychiatric disorders in patients with epilepsy is extremely important, because it improves the quality of life and aids in better seizure control. Newer antiepileptics with less interaction with psychotropics and less behavioural manifestations should be used for management of epilepsy; and psychotropics having low potential for lowering seizure threshold are generally preferred. A holistic approach to assess psychiatric comorbidity and judicious use of medicine can help in comprehensive patient care planning and reduced health burden.